Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA

BACKGROUND: Prostate-specific antigen (PSA) is commonly used as a serum biomarker for the detection of prostate cancer. However, levels of PSA in serum do not reliably distinguish aggressive prostate cancer from non-aggressive disease. Therefore, there is an urgent need for biomarkers that can diffe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Proteomics
Auteurs principaux: Wang, Ce, Höti, Naseruddin, Lih, Tung-Shing Mamie, Sokoll, Lori J., Zhang, Rui, Zhang, Zhen, Zhang, Hui, Chan, Daniel W.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451306/
https://ncbi.nlm.nih.gov/pubmed/30996714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-019-9234-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires